ImmunityBio (26CA.F) Q1 2025 Earnings

3MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.19
-0.16
-0.12
-0.09

Details

Expected EPS
-0.190774
Actual EPS
-0.0858483
Surprise EPS
0.1
Surprise Percent
+55%

Description

ImmunityBio (26CA.F) has reported earnings of -0.0858483 per share for Q1 2025.

0 Comments

Share your thoughts